Sophia Genetics SA

NASDAQ SOPH

Download Data

Sophia Genetics SA Price to Book Ratio (P/B) on June 03, 2024: 2.74

Sophia Genetics SA Price to Book Ratio (P/B) is 2.74 on June 03, 2024, a 88.94% change year over year. The price to book ratio compares the market price per share of a company's stock to its book value per share. It is calculated by dividing the market capitalization by the shareholders' equity minus treasury stock, divided by the number of outstanding shares. This ratio provides insights into how the market values a company relative to its book value. A ratio above 1 indicates the market values the company more than its book value, suggesting positive market sentiment.
  • Sophia Genetics SA 52-week high Price to Book Ratio (P/B) is 2.74 on June 03, 2024, which is 0.00% below the current Price to Book Ratio (P/B).
  • Sophia Genetics SA 52-week low Price to Book Ratio (P/B) is 0.86 on August 17, 2023, which is -68.51% below the current Price to Book Ratio (P/B).
  • Sophia Genetics SA average Price to Book Ratio (P/B) for the last 52 weeks is 1.68.
NASDAQ: SOPH

Sophia Genetics SA

CEO Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date July 23, 2021
Location Switzerland
Headquarters Rue du Centre 172, Saint-Sulpice, Switzerland, 1025
Employees 430
Sector Healthcare
Industry Health information services
Description

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Similar companies

FORA

Forian Inc

USD 2.84

9.65%

MDRX

Veradigm Inc.

USD 9.60

1.05%

SLP

Simulations Plus Inc

USD 45.99

-4.66%

PINC

Premier Inc

USD 19.09

0.90%

StockViz Staff

September 8, 2024

Any question? Send us an email